AEs	Adverse Events
ADAs	Anti-Drug Antibodies
BD	Biodisponibility
CHMP	Committee for Medicinal Products for Human Use
CQAs	Critical Quality Attributes
EMA	European Medicine Administration
EEE	European Economic Area
EU	European Union
Fab	Fragment Antigen-Binding
Fc	Fragment Crystallizable
FcRn	Neonatal Fragment Crystallizable Receptor
FcγR	Fragment Crystallizable-Gamma Receptor
FDA	Food and Drug Administration
FIMEA	Finnish Medicines Agency
GCSF	Granulocyte Colony-Stimulating Factor
GH	Growth Hormone
ICH	International Conference of Harmonization
INFα	Interferon Alpha
INFβ	Interferon Beta
INN	International Naming System
RP	Reference Product
WHO	World Health Organization
mAb	Monoclonal Antibody
MA	Marketing Authorization
MS	Member State
PK	Pharmacokinetic
PD	Pharmacodynamics
PTMs	Post-Translational Modifications
PV	Pharmacovigilance
QbD	Quality-by-Design
QTPP	Quality Target Product Profile
SmPC	Summary of Product Characteristics
tRNA	Transfer RNA